雾化吸入干扰素-α治疗儿童疱疹性咽峡炎临床疗效评价

doi:10.3969/j.issn.1000-8535.2022.02.017

摘要/Abstract

摘要： 目的探讨雾化吸入干扰素-α治疗对儿童疱疹性咽峡炎的治疗效果的影响。方法本研究纳入2019年1月—2021年1月在清远市妇幼保健院住院治疗的126例疱疹性咽峡炎儿童。所有参与该研究的患儿被随机平均分为2组:对照组(63人)和干预组(63人)。对照组进行常规治疗方案,干预组在对照组基础上雾化吸入干扰素-α治疗。比较2组治疗效果的差异性。结果干预组患儿平均发热天数(1.86±0.97天)较对照组(2.44±0.89天)低;干预组心肌酶升高比例较对照组低,组间差异有统计学意义(P<0.01)。干预组中显效(50.8%)占主要比例,而对照组中有效(74.6%)占主要比例,并且干预组总有效率(98.4%)高于对照组(96.8%)(P<0.05)。干预组住院天数(5.02±1.85天)较对照组(5.68±1.68天)降低,组间差异有统计学意义(P<0.05)。结论在常规治疗的基础上加用雾化吸入干扰素-α治疗对提高儿童疱疹性咽峡炎的疗效有促进作用,值得临床推广。

关键词: 干扰素-α, 疱疹性咽峡炎, 心肌酶, 疗效

Abstract: Objective To investigate the effect of nebulized inhalation of interferon-α on the therapeutic effect of herpes angina in children. Methods This study included 126 children with herpetic angina who were hospitalized in Maternal and Child Health Hospital of Qingyuan City from January 2019 to January 2021.All children participating in the study were randomly divided into 2 groups: control group (63 children) and intervention group (63 children). The control group received conventional treatment, and the intervention group was treated with aerosol inhalation of interferon-α on the basis of the control group.The difference of the treatment effect between the two groups were compared. Results The average number of fever days of children in the intervention group (1.86±0.97 days) was lower than that of the control group (2.44±0.89 days); the increase of myocardial enzymes in the intervention group was lower than that of the control group, and the difference was statistically significant (P<0.01). The “obviously effective” (50.8%) in the intervention group accounted for the main proportion, while the “effective” (74.6%) in the control group accounted for the main proportion, and the total effective rate of the intervention group (98.4%) was higher than that of the control group (96.8%,P< 0.05). The length of hospitalization in the intervention group (5.02±1.85 days) was smaller than that of the control group (5.68±1.68 days), and the difference was statistically significant (P<0.05). Conclusion The addition of nebulized interferon-α on the basis of conventional treatment could improve the curative effect of herpetic angina in children, and it is worthy of clinical promotion.

Key words: interferon-α, herpetic angina, myocardial enzymes, clinical efficacy

刘志伟, 黄志荣. 雾化吸入干扰素-α治疗儿童疱疹性咽峡炎临床疗效评价[J]. 广州医药, 2022, 53(2): 82-86.

LIU Zhiwei, HUANG Zhirong. Evaluation on the clinical efficacy of interferon-α nebulized inhalation in the treatment of herpetic angina in children[J]. Guangzhou Medical Journal, 2022, 53(2): 82-86.

参考文献

[1] 中华医学会儿科学分会感染学组, 国家感染性疾病医疗质量控制中心.疱疹性咽峡炎诊断及治疗专家共识(2019年版)[J].中华儿科杂志, 2019,57(3):177-180.
[2] TAKECHI M, FUKUSHIMA W, NAKANO T, et al.Nationwide survey of pediatric inpatients with hand, foot, and mouth disease, herpangina, and associated complications during an epidemic period in Japan: estimated number of hospitalized patients and factors associated with severe cases[J].J Epidemiol, 2019,29(9):354-362.
[3] YE Y Z, DOU Y L, HAO J H, et al. Efficacy and safety of interferon alpha-2b spray for herpangina in children: A randomized, controlled trial[J].Int J Infect Dis, 2021(107):62-68.
[4] 朱经林,刘井秀,刘小花,等.小儿疱疹性咽峡炎血常规特点及其临床意义[J].现代医院,2020,20(3):463-465.
[5] BECK M A.Increased virulence of coxsackievirus B3 in mice due to vitamin E or selenium deficiency[J].J Nutr, 1997,127(5 Suppl):966S-970S.
[6] WU Z, PENG H, DU Q, et al. GYY4137, a hydrogen sulfidereleasing molecule, inhibits the inflammatory response by suppressing the activation of nuclear factorkappa B and mitogenactivated protein kinases in Coxsackie virus B3 infected rat cardiomyocytes[J].Mol Med Rep, 2015,11(3):1837-1844.
[7] 钱招昕,黄寒,林晓娟.川芎嗪对柯萨奇B3病毒感染乳鼠心肌细胞的保护作用及信号转导机制研究[J].中国当代儿科杂志, 2009,11(8):687-690.
[8] 陈全景, 王春晖.疱疹性咽峡炎患儿心肌酶检测临床评价[J].山东医药, 2007(19):149-150.
[9] 贺锦华, 赵小红, 马利维.118例疱疹性咽峡炎患儿心肌损伤临床分析[J].检验医学与临床, 2012(19):2442-2443.
[10] 曹甦, 姚惠辉, 牛锋.重组人干扰素α-1b雾化治疗婴幼儿疱疹性咽峡炎的临床效果[J].中国医药导报, 2019,16(20):156-158.
[11] 崔智亮, 张俊, 叶锦玲, 等.儿童疱疹性咽峡炎采用不同治疗方法的对比研究[J].广州医药, 2019,50(5):6-9.
[12] DATE I, KOYA T, SAKAMOTO T, et al. Interferon-alpha-induced dendritic cells generated with human platelet lysate exhibit elevated antigen presenting ability to cytotoxic T lymphocytes[J].Vaccines (Basel), 2020,9(1):10.
[13] GILL U S, PEPPA D, MICCO L, et al. Interferon alpha induces sustained changes in NK cell responsiveness to hepatitis B viral load suppression in vivo[J].PLoS Pathog, 2016,12(8):e1005788.
[14] KWAA A, TALANA C, BLANKSON J N.Interferon alpha enhances NK cell function and the suppressive capacity of HIV-specific CD8(+) T cells[J].J Virol, 2019,93(3):e01541-18.

[1]	李俊. 补阳还五汤加减治疗肾病综合征的疗效及临床价值[J]. 广州医药, 2022, 53(2): 48-51.
[2]	陈夏. 宫腔镜电切术联合炔诺酮对围绝经期功能失调性子宫出血患者治疗的临床效果[J]. 广州医药, 2022, 53(2): 99-101.
[3]	刘芳, 武明莉, 杨小风, 娄欢, 张颖. 不同保守治疗方法在输卵管妊娠中的治疗分析[J]. 广州医药, 2022, 53(2): 124-127.
[4]	谢汉清, 黄钻明, 杨艳萍, 胡寿祥. 电视胸腔镜手术与传统开胸手术在胸腺瘤治疗中的临床疗效对比[J]. 广州医药, 2022, 53(1): 114-116.
[5]	梁长征, 陈朝兴, 黎卓, 梁聚兴. 口腔种植修复和常规修复在牙列缺损治疗中的有效性分析[J]. 广州医药, 2021, 52(6): 72-75.
[6]	张欢欢, 柯明珠, 麦桥勋. 补肾养骨口服液对强直性脊柱炎的疗效与安全性:随机对照试验[J]. 广州医药, 2021, 52(6): 119-122.
[7]	孙翔, 邓晓辉, 王晓柯. 应用神经内镜手术治疗基底节区脑出血的疗效观察[J]. 广州医药, 2021, 52(5): 44-47.
[8]	杨少宾, 张丽, 李俊娜. 上消化道早癌与癌前病变内镜下治疗的效果评价[J]. 广州医药, 2021, 52(5): 76-79.
[9]	闫利辉, 姚海亮, 刘琳, 张娴, 谢冰. 牙周基础治疗联合口腔正畸对牙周炎患者炎症细胞因子的疗效分析[J]. 广州医药, 2021, 52(5): 122-126.
[10]	骆超锋, 梁叠锋, 关国宏. 瑞格列奈联合胰岛素治疗2型糖尿病临床疗效及对患者血糖水平的影响[J]. 广州医药, 2021, 52(4): 65-67.
[11]	王帅, 文仲勇, 李莉芳, 王洪燕, 黄浩. 腹腔镜下卵巢癌减灭术联合化疗治疗卵巢癌的疗效观察[J]. 广州医药, 2021, 52(3): 45-47.
[12]	李文升, 冯良恩, 张强. 不同年龄段患者椎间孔镜下腰椎间盘突出症疗效分析[J]. 广州医药, 2021, 52(2): 73-76.
[13]	邹缄. 避孕药结合宫腔镜手术治疗子宫内膜息肉的临床疗效与安全性分析[J]. 广州医药, 2021, 52(2): 105-107.
[14]	司徒宝珠. MP-SAT作为支原体肺炎患儿疗效监测指标的可行性分析[J]. 广州医药, 2021, 52(1): 87-91.
[15]	陈凤明, 肖小玲, 曾国庆, 苏怡. 微信式延续护理对真菌性外耳道炎患者心理及治疗效果的影响[J]. 广州医药, 2020, 51(4): 100-103.